The beneficial effect of a PDE4 inhibitor in a patient with juvenile‐onset intractable pityriasis rubra pilaris without CARD14 mutation
- 26 December 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (1), e14714
- https://doi.org/10.1111/dth.14714
Abstract
Click on the article title to read more.Keywords
This publication has 6 references indexed in Scilit:
- Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient surveyDermatologic Therapy, 2019
- A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor ApremilastActa Dermato-Venereologica, 2018
- CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilarisJournal of the American Academy of Dermatology, 2018
- Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 MutationsJAMA Dermatology, 2017
- Pityriasis Rubra PilarisAmerican Journal of Clinical Dermatology, 2010
- Pityriasis rubra pilaris*Clinical and Experimental Dermatology, 1980